Strengthening Community Addiction Services in Vietnam

Study Overview
=================
Brief Summary
-----------------
This study aims to develop and test an intervention to enhance the addiction service continuum with the joint effort of commune health workers and family members of people who use drugs in Vietnam.

Detailed Description
-----------------
The study will develop and test an intervention to strengthen a continuum of addiction services. The intervention, entitled Community Care Consortium (CCC), features community health workers' joint effort with family members to provide patient-centered, individualized addiction care and support. The intervention will be developed and tested through three phases in three regions of Vietnam (Ninh Binh, Da Nang, and Can Tho). In Phase 1, we will conduct formative studies with commune (community) health workers (CHW), community representatives, PWUD, and their family members to identify barriers to addiction service utilization and discuss potential strategies to establish a continuum of addiction services. Based on the formative study findings, the CCC Intervention and its implementation plans will be developed through workgroup meetings with researchers, community members, and target users. In Phase 2, the CCC Intervention will be piloted in three communes and revised based on acceptability/feasibility data, process evaluation, and feedback from field staff and participants. In Phase 3, a randomized controlled trial of the CCC Intervention will be conducted in 60 communes, which will be randomized to either an intervention condition or a control condition (30 communes in each condition). A total of 720 PWUD, 720 of their family members, and 180 commune health workers (CHW) will participate in the study. The intervention outcomes on PWUD, CHW, and family members will be assessed with the data collected at baseline, 3-, 6-, 9- and 12-month follow-ups.

Official Title
-----------------
Strengthening Addiction Care Continuum Through Community Consortium in Vietnam

Conditions
-----------------
Addiction, Opioid

Intervention / Treatment
-----------------
* Behavioral: Community Care Consortium (CCC)


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Age 18 or older Having a history of drug use Having disclosed drug using status to at least one of his/her family members and is willing to invite this family member to our study Currently residing in the selected communes Voluntary written informed consent Exclusion Criteria: Inability to give informed consent

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Supportive Care
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Intervention communes<br>CCC intervention | Behavioral: Community Care Consortium (CCC)<br>* The intervention will train community health workers to take an active role in the drug control and addiction service delivery in the community.<br>|
| No Intervention: Control communes<br>Standard care | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| PWUD's STTR fulfillment score | This overall score consists of individual indicators in 4 domains: Seek,Test, Treat, Retain | Changes from baseline to 3-, 6-, 9- and 12- month follow-ups | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| CHW's addiction-related service provision and support | CHW's service provision and support such as patient referrals and support for treatment retention measured by frequencies of appointment reminder, follow-up activities | Changes from baseline to 3-, 6-, 9- and 12- month follow-ups |